Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4405148
[patent_doc_number] => 06171857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Leucine zipper protein, KARP-1 and methods of regulating DNA dependent protein kinase activity'
[patent_app_type] => 1
[patent_app_number] => 9/173914
[patent_app_country] => US
[patent_app_date] => 1998-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 38
[patent_no_of_words] => 28954
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171857.pdf
[firstpage_image] =>[orig_patent_app_number] => 173914
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/173914 | Leucine zipper protein, KARP-1 and methods of regulating DNA dependent protein kinase activity | Oct 15, 1998 | Issued |
Array
(
[id] => 1174730
[patent_doc_number] => 06746867
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-08
[patent_title] => 'Mammalian mesoderm induction early response (MIER) gene family'
[patent_app_type] => B1
[patent_app_number] => 09/170984
[patent_app_country] => US
[patent_app_date] => 1998-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 53
[patent_no_of_words] => 34858
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/746/06746867.pdf
[firstpage_image] =>[orig_patent_app_number] => 09170984
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/170984 | Mammalian mesoderm induction early response (MIER) gene family | Oct 12, 1998 | Issued |
Array
(
[id] => 4355584
[patent_doc_number] => 06218370
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Glycerolipidic compounds used for the transfer of an active substance into a target cell'
[patent_app_type] => 1
[patent_app_number] => 9/171129
[patent_app_country] => US
[patent_app_date] => 1998-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 17085
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218370.pdf
[firstpage_image] =>[orig_patent_app_number] => 171129
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/171129 | Glycerolipidic compounds used for the transfer of an active substance into a target cell | Oct 12, 1998 | Issued |
Array
(
[id] => 1376333
[patent_doc_number] => 06562960
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Oligonucleotide analogues'
[patent_app_type] => B1
[patent_app_number] => 09/142212
[patent_app_country] => US
[patent_app_date] => 1998-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11264
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562960.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142212
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142212 | Oligonucleotide analogues | Oct 8, 1998 | Issued |
Array
(
[id] => 7625609
[patent_doc_number] => 06723560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-20
[patent_title] => 'Using polyamide nucleic acid oligomers to engender a biological response'
[patent_app_type] => B2
[patent_app_number] => 09/168791
[patent_app_country] => US
[patent_app_date] => 1998-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 26634
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723560.pdf
[firstpage_image] =>[orig_patent_app_number] => 09168791
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/168791 | Using polyamide nucleic acid oligomers to engender a biological response | Oct 7, 1998 | Issued |
Array
(
[id] => 4409650
[patent_doc_number] => 06172216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Antisense modulation of BCL-X expression'
[patent_app_type] => 1
[patent_app_number] => 9/167921
[patent_app_country] => US
[patent_app_date] => 1998-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19127
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172216.pdf
[firstpage_image] =>[orig_patent_app_number] => 167921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/167921 | Antisense modulation of BCL-X expression | Oct 6, 1998 | Issued |
Array
(
[id] => 4352464
[patent_doc_number] => 06291438
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use'
[patent_app_type] => 1
[patent_app_number] => 9/167375
[patent_app_country] => US
[patent_app_date] => 1998-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 53
[patent_no_of_words] => 26550
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291438.pdf
[firstpage_image] =>[orig_patent_app_number] => 167375
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/167375 | Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use | Oct 5, 1998 | Issued |
Array
(
[id] => 4214312
[patent_doc_number] => 06087164
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Methods and compositions for inducing tumor-specific cytotoxicity'
[patent_app_type] => 1
[patent_app_number] => 9/165240
[patent_app_country] => US
[patent_app_date] => 1998-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 12876
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087164.pdf
[firstpage_image] =>[orig_patent_app_number] => 165240
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/165240 | Methods and compositions for inducing tumor-specific cytotoxicity | Sep 30, 1998 | Issued |
Array
(
[id] => 4320117
[patent_doc_number] => 06248724
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of use'
[patent_app_type] => 1
[patent_app_number] => 9/162484
[patent_app_country] => US
[patent_app_date] => 1998-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 39469
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248724.pdf
[firstpage_image] =>[orig_patent_app_number] => 162484
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/162484 | Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of use | Sep 24, 1998 | Issued |
Array
(
[id] => 4271641
[patent_doc_number] => 06245748
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Inhibition of an FGF-binding protein using ribozymes'
[patent_app_type] => 1
[patent_app_number] => 9/160588
[patent_app_country] => US
[patent_app_date] => 1998-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3538
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245748.pdf
[firstpage_image] =>[orig_patent_app_number] => 160588
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/160588 | Inhibition of an FGF-binding protein using ribozymes | Sep 24, 1998 | Issued |
Array
(
[id] => 4124060
[patent_doc_number] => 06127173
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-03
[patent_title] => 'Nucleic acid catalysts with endonuclease activity'
[patent_app_type] => 1
[patent_app_number] => 9/159274
[patent_app_country] => US
[patent_app_date] => 1998-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13880
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/127/06127173.pdf
[firstpage_image] =>[orig_patent_app_number] => 159274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/159274 | Nucleic acid catalysts with endonuclease activity | Sep 21, 1998 | Issued |
Array
(
[id] => 4013693
[patent_doc_number] => 05962672
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Antisense modulation of RhoB expression'
[patent_app_type] => 1
[patent_app_number] => 9/156979
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18267
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962672.pdf
[firstpage_image] =>[orig_patent_app_number] => 156979
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/156979 | Antisense modulation of RhoB expression | Sep 17, 1998 | Issued |
Array
(
[id] => 4013680
[patent_doc_number] => 05962671
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Antisense modulation of fan expression'
[patent_app_type] => 1
[patent_app_number] => 9/156425
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19972
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962671.pdf
[firstpage_image] =>[orig_patent_app_number] => 156425
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/156425 | Antisense modulation of fan expression | Sep 17, 1998 | Issued |
Array
(
[id] => 4237234
[patent_doc_number] => 06143729
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-07
[patent_title] => 'Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/125825
[patent_app_country] => US
[patent_app_date] => 1998-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 8606
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/143/06143729.pdf
[firstpage_image] =>[orig_patent_app_number] => 125825
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/125825 | Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof | Sep 10, 1998 | Issued |
09/139234 | BACTERIAL COMPOSITIONS AND METHODS OF USE | Aug 24, 1998 | Abandoned |
09/137059 | NUCLEIC ACID AGENTS FOR DETECTING TARGET MOLECULES AND METHODS FOR THEIR USE | Aug 19, 1998 | Abandoned |
Array
(
[id] => 1459370
[patent_doc_number] => 06426403
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'TRAF family molecules, polynucleotides encoding them, and antibodies against them'
[patent_app_type] => B1
[patent_app_number] => 09/138277
[patent_app_country] => US
[patent_app_date] => 1998-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 15360
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426403.pdf
[firstpage_image] =>[orig_patent_app_number] => 09138277
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/138277 | TRAF family molecules, polynucleotides encoding them, and antibodies against them | Aug 17, 1998 | Issued |
Array
(
[id] => 4268229
[patent_doc_number] => 06223127
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Polymorphism detection utilizing clustering analysis'
[patent_app_type] => 1
[patent_app_number] => 9/134758
[patent_app_country] => US
[patent_app_date] => 1998-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 4977
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/223/06223127.pdf
[firstpage_image] =>[orig_patent_app_number] => 134758
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/134758 | Polymorphism detection utilizing clustering analysis | Aug 13, 1998 | Issued |
Array
(
[id] => 1602460
[patent_doc_number] => 06432638
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Triple helix recognition of DNA'
[patent_app_type] => B1
[patent_app_number] => 09/128732
[patent_app_country] => US
[patent_app_date] => 1998-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 9360
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09128732
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/128732 | Triple helix recognition of DNA | Aug 3, 1998 | Issued |
Array
(
[id] => 4096785
[patent_doc_number] => 06099823
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-08
[patent_title] => 'Compositions and methods for the treatment and diagnosis of cardiovascular disease'
[patent_app_type] => 1
[patent_app_number] => 9/126640
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 52809
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/099/06099823.pdf
[firstpage_image] =>[orig_patent_app_number] => 126640
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/126640 | Compositions and methods for the treatment and diagnosis of cardiovascular disease | Jul 29, 1998 | Issued |